NEW YORK – Twist Bioscience and Biotia said on Wednesday they have been granted Emergency Use Authorization from the US Food and Drug Administration for their SARS-CoV-2 Next-Generation Sequencing assay.
NEW YORK – Twist Bioscience and Biotia said on Wednesday they have been granted Emergency Use Authorization from the US Food and Drug Administration for their SARS-CoV-2 Next-Generation Sequencing assay.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.